Skip to main content

Beyond Air, Inc.

corporate_fare Company Profile

Beyond Air, Inc.

XAIR·NASDAQ·Industrial Applications And Services·CIK 0001641631

Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company that develops a platform of nitric oxide (NO) generators and delivery systems, known as the LungFit® platform. This platform is designed to generate NO from ambient air. The company's initial device, LungFit® PH, received premarket approval (PMA) from the FDA in June 2022. The NO produced by the LungFit® PH system is approved to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term neonates (greater than 34 weeks gestation) who have hypoxic respiratory failure linked to clinical or echocardiographic evidence of pulmonary hypertension, when used with ventilatory support and other suitable agents. This condition is commonly referred to as persistent pulmonary hypertension of the newborn (PPHN). The LungFit® platform can generate NO at concentrations up to 400 parts per million (ppm) for delivery to a patient's lungs, either directly or through a ventilator. LungFit® can deliver NO continuously or for a set duration at various flow rates, and it can either adjust the dose on demand or maintain a constant dose. Beyond Air, Inc. began marketing LungFit® PH in the United States for PPHN as a medical device in July 2022. In November 2024, the company received European CE mark approval for the LungFit PH® system for two indications: the treatment of infants greater than 34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, to improve oxygenation and reduce the need for extracorporeal membrane oxygenation; and the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years, in conjunction with heart surgery, to selectively decrease pulmonary arterial pressure and improve right ventricular function and oxygenation. LungFit® can be used for patients on ventilators who require NO, as well as for patients with chronic or acute severe lung infections, by delivering NO at concentrations greater than 100 ppm through a breathing mask or similar device.

Beyond Air, Inc. (NASDAQ:XAIR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 35 items for XAIR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for XAIR spans 10-Q, 424B3, 8-K, S-3.

Recent high-impact activity:

  • Beyond Air 10-Q: $16.3M Six-Month Loss, Going-Concern Warning, $13.7M Cash
  • Beyond Air Posts Wider-Than-Expected $3.49 Loss as Revenue Edges Past Estimates
  • Beyond Air Preannounces Record $2.3M Quarterly Revenue, Up 30% Sequentially
  • FDA Grants Breakthrough Device Designation to Beyond Air's LungFit GO for NTM-PD
  • Beyond Air Sells NeuroNOS Stake for Equity and Milestone Payments

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$7.68M
Net Income
-$33.25M
Diluted EPS
-$4.01
Op. Cash Flow
-$18.14M
Free Cash Flow
-$19.17M
Gross Profit
$252K
Operating Income
-$29.04M
Cash & Equivalents
$6.74M
Debt / Equity
0.00×
Net Margin
-433.0%
Shares Outstanding
11.79M sh
Source: 10-K · filed 2026-06-26 · accession 0001493152-26-030287

Short Interest & Short Volume

4.79 days to cover

FINRA reported short interest of 75,069 shares in XAIR as of the October 30, 2026 settlement, a 25.8% increase from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 45.9% of XAIR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)75,069 shares as of October 30, 2026
Change vs prior period▲ 25.8%
Days to cover4.79 at avg daily volume of 15,675
Daily short volume (FINRA facilities)45.9% of 13,324 shares on November 20, 2026
5-day average short volume38.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for XAIR, detected from its recent SEC filings.

ATM program1 shelf registrationreverse split

Resale Registration Filed · Selling Stockholders Identified

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with X →
$1.54
52-week range · as of 2026-11-12 $1.54 – $53.2
Market cap
$2.57M
Volume
27.7K (0.5× avg)
3-mo avg 54.2K
Live data · 2026-11-21 06:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XAIR - Latest Insights

XAIR
Nov 12, 2026, 9:17 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $1.54 info
Change: -$0.460 (-23%) info
Market Cap: $2.566M info
XAIR
Nov 11, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.54 info
Change: -$0.640 (-29%) info
Market Cap: $2.566M info
XAIR
Oct 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Updated Oct 8, 8:44 AM ET — Beyond Air announced preliminary unaudited revenue of approximately $2.3 million for the quarter ended September 30, 2026, up 30% sequentia…
Price at Filing: $2.45
Real-time Price: $1.54 info
Change: -$0.9097 (-37%) info
Market Cap: $2.566M info
XAIR
Aug 31, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $1.54 info
Change: -$4.19 (-73%) info
Market Cap: $2.566M info
XAIR
Aug 25, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.78
Real-time Price: $1.54 info
Change: -$3.24 (-68%) info
Market Cap: $2.566M info
XAIR
Aug 24, 2026, 5:25 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $4.91
Real-time Price: $1.54 info
Change: -$3.37 (-69%) info
Market Cap: $2.566M info
XAIR
Aug 18, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $1.54 info
Change: -$4.19 (-73%) info
Market Cap: $2.566M info
XAIR
Aug 17, 2026, 4:50 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $5.71
Real-time Price: $1.54 info
Change: -$4.17 (-73%) info
Market Cap: $2.566M info
XAIR
Aug 13, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.92
Real-time Price: $1.54 info
Change: -$5.38 (-78%) info
Market Cap: $2.566M info
XAIR
Aug 06, 2026, 4:37 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.56
Real-time Price: $1.54 info
Change: -$4.02 (-72%) info
Market Cap: $2.566M info
XAIR
Jul 31, 2026, 6:55 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $5.93
Real-time Price: $1.54 info
Change: -$4.39 (-74%) info
Market Cap: $2.566M info
XAIR
Jul 31, 2026, 6:21 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $5.28
Real-time Price: $1.54 info
Change: -$3.74 (-71%) info
Market Cap: $2.566M info
XAIR
Jul 31, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.50
Real-time Price: $1.54 info
Change: -$3.96 (-72%) info
Market Cap: $2.566M info
XAIR
Jul 09, 2026, 9:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4301
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 26, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.481
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 26, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.481
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 26, 2026, 4:06 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.495
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 26, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.5499
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4099
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
XAIR
Jun 22, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3555
Real-time Price: $1.54 info
Change: Reverse Stock Split info
Market Cap: $2.566M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets